Granted
The Board granted an initial 60 percent evaluation for polycythemia vera, as the Veteran was prescribed molecularly targeted therapy to control red blood cell count.
The deciding factor: The available evidence showed that the Veteran's condition required continuous biologic therapy or myelosuppressive agents, consistent with a 60 percent rating under Diagnostic Code 7704.
- Claimed conditions
- polycythemia vera
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- October 24, 2025
- Citation
- A25092314
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.